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Background: The present study investigated whether patients with CF who are studying or working report a better HRQoL in comparison to non-
working/studying patients.
Methods: 57 adult CF patients completed the Cystic Fibrosis Questionnaire—Revised, a CF-specific measure of HRQoL. Medical condition was
quantified in terms of FEV1 % predicted, BMI, Pseudomonas aer. status, pancreatic status (PS), having an indwelling catheter device (PAC), CF
Related Diabetes Mellitus and nutritional status.
Results: Mean age was 26.7 years (SD 8.1), mean FEV1 % predicted was 65.09 (SD 22.18), mean BMI was 21.23 (SD 3.45). FEV1 % predicted
was related to HRQoL domains Physical Functioning and General Health (r=0.27 and 0.38 respectively, pb0.05). A higher BMI was associated
with better scores on Eating Disturbances (= fewer problems; r=0.44, pb0.01) and a better perception of Weight (r=0.43, pb0.01) and Body
Image (r=0.28, pb0.05). Analysis of variance showed that specific domains of HRQoL were related to diabetes (Weight), taking caloric
supplements (Body Image and Weight) and/or PAC (Physical Functioning, Treatment Burden, Role, Weight). Twenty-four patients worked/
studied, these patients had a higher FEV1, and fewer had Pseudomonas aer. or a PAC or took high caloric supplements, compared to non-working/
studying patients. After controlling for medical parameters, patients who were working/studying scored higher than non-working/studying patients
on Physical Functioning, Role Functioning and Social Functioning.
Conclusions: CF patients' HRQoL is related to medical status. The non-working/studying CF patients in this sample had greater disease severity
and reported a lower quality of life than their working/studying peers, even after controlling for relevant medical parameters. The decision to stop
work/study for CF patients is difficult and affects patients' personal, social and financial well-being.
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1.1. Cystic fibrosis
With advances in the treatment and care of patients with
cystic fibrosis, the life expectancy for this population has risen
markedly to approximately 35–40 years of age [1]. With this
improved life expectancy, more patients are able to attend
school, obtain diplomas and work in either full- or part-time
positions and as patients live longer they are more interested in
pursuing adult, age-appropriate activities.⁎ Corresponding author. CF Centre, University Hospital Leuven, Herestraat
49, B-3000 Leuven, Belgium. Tel.: +32 16 340268; fax: +32 16 343817.
E-mail address: trudy.havermans@uzleuven.be (T. Havermans).
1569-1993/$ - see front matter © 2009 European Cystic Fibrosis Society. Publishe
doi:10.1016/j.jcf.2009.03.0021.2. HRQoL and CF
Over the past 15 years, Health-related Quality of Life
(HRQoL) research has gained substantial interest in psycholo-
gical and medical research of cystic fibrosis (CF). HRQoL is a
multidimensional construct that encompasses physical, psycho-
logical, social and functional domains of daily life and measures
the impact of health and illness on these areas of functioning.
Several researchers have measured HRQoL in patients with
CF in relation to psychosocial, demographic and/or clinical
factors [2–6] and CF-specific measures of HRQoL in different
languages have been developed [7–9]. HRQoL measures have
been used in clinical trials [10,11]. Recent reviews have
reported on HRQoL as an outcome measure in clinical trials in
adults [12] and children [13], in association with antibioticd by Elsevier B.V. All rights reserved.
Table 1
Characteristics of the study group.
Male 29
Female 28
Mean age (SD) 26.79 (8.15)
Lung function FEV1 (mean, SD) 65.09 (22.18)
BMI (mean, SD) 21.23 (3.45)
Work/study No=13
Yes=24
High caloric supplements No=44
Yes=13
PACa No=37
Yes=20
Pancreatic status b PS=9
PI=48
Diabetes (CFRDM) c No=47
Yes=10
Psa d Group 1=13
Group 2=20
Group 3=24
a PAC = presence or absence of central venous implantable device.
b Pancreatic status: PI = pancreas insufficient; PS = pancreas sufficient.
c Treated with insulin therapy.
d Pseudomonas aeruginosa (PA) colonization status: group 1 = negative for
PA, group 2 = positive non-multiresistant and group 3 = positive multiresistant.
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reveals various factors that are associated with domains of
HRQoL, including coping, medical parameters and compliance.
An important overall result is that medical parameters, used as
indicators of disease severity (e.g. lung function, body mass
index, exercise performance) are only modestly related to
HRQoL scores [4,6].
1.3. Work and CF
With patients living longer the issue of work (or school) has
become important in CF HRQoL research. Two studies
specifically looked at traditional clinical parameters and
HRQoL in relation to patients' work status. For example,
Burker et al. found that FEV1 % predicted did not differentiate
between patients who were or were not working [16] and they
reported that patients who were working had significantly lower
depression scores and a higher educational level than those who
were not working. In line with this, Hogg et al. [17] reported a
strong relationship between hours worked and patients'
perception of disability and quality of life (‘mastery of disease’).
The data from these studies suggested that whether a patient
with CF is working or not is not solely related to their medical
situation. In clinical practice we observe that patients who are
employed find it hard to reduce their working hours or stop
working even though they are advised to do so in order to
stabilize their medical situation. Some patients will continue
working down to a lung function of 25–30 FEV1 % predicted.
Patients say ‘I feel in control of my life when I work’ or ‘I need
to work to feel appreciated.’Working may increase perceptions
of HRQoL despite the fact that most do realize this places them
at increased risk of deteriorating health.
With regard to HRQoL, medical status and work/study status
three hypotheses have been constructed based on the literature
and clinical observation. Hypothesis 1 states that health status
will be positively related to higher scores on HRQoL, using
FEV1 % predicted, Body Mass Index, Pseudomonas aeruginosa
status, pancreatic status, having an indwelling catheter device,
CF Related Diabetes Mellitus (CFRDM) and nutritional status
as indicators of clinical status. Hypothesis 2 states that patients
who work/study will have less severe disease than those who do
not work or study. Hypothesis 3 states that after controlling for
medical parameters, patients in a work/study situation will rate
their HRQoL higher than those who are not in a work/study
situation.
2. Method
2.1. Study design and subjects
This cross-sectional study recruited patients consecutively
attending the outpatient clinic at the Adult CF Centre at the
University Hospital Leuven between September 2006 and
September 2007. As the measure is part of the annual review,
ethics approval is not required. Patients whose lung disease was
stable were asked to complete a quality of life questionnaire
during an outpatient clinic visit as part of their annual review.Patients who had been transplanted were not included. Fifty
seven patients (67% of the adult CF population) completed the
questionnaires. Table 1 shows patients characteristics. None of
the patients declined to complete the questionnaires, but patients
experiencing a CF exacerbation or complication (e.g. acute
severe hemoptysis, pneumothorax, DIOS, PAC related infec-
tion), or those admitted for treatment with IV antibiotics, were
excluded from the study.
2.2. Measures
2.2.1. Medical variables
Objective assessment of disease status (medical status)
included spirometry (forced expiratory volume in 1 second;
FEV1 % predicted) and body mass index (BMI). In addition, the
following variables were included: the presence or absence of
central venous implantable device (portacath or PAC), diabetic
status (presence or absence of Cystic Fibrosis Related Diabetes
Mellitus treated with insulin therapy (CFRDM)), exocrine
pancreatic status (PI = pancreas insufficient; PS = pancreas
sufficient), Pseudomonas aeruginosa (PA) colonization status
(group 1 = negative for PA, group 2 = positive non-
multiresistant and group 3 = positive multiresistant) and
nutritional status (taking high caloric supplements or not).
These medical data were obtained from the patients' medical
record on the date the questionnaire was completed.
2.2.2. HRQoL
HRQoL was measured using a Dutch translation of the CFQ-
R Teen/Adult version of the CFQ-R [18]. It consists of 44 items
across 12 scales (Table 2). The CFQ-R Teen/Adult version has
good reliability, with Cronbach alpha's ranging from 0.67 to
0.94. Response choices generally included ratings of frequency
and difficulty on a 4-point scale (1 = always to 4 = never; 1 = a
Table 2
CFQ—teen/adult scales.
HRQoL dimensions Items, no. Sample items
Physical functioning 8 Walking as fast as others
Role 2 How often were you absent from school/work during the last 2 weeks because of your illness or treatments?
Vitality 4 You felt tired
Emotional functioning 5 You felt worried
Social 5 I get together with my friends a lot
Body image 3 I think I am too thin
Eating disturbances 3 I have to force myself to eat
Treatment burden 2 Compared to 3 months ago, how much time do you currently spend on your treatment?
Health perceptions 3 I feel healthy
Weight 1 Have you had trouble gaining weight
Respiratory symptoms 6 Have you had trouble breathing
Digestive symptoms 2 Have you had abdominal pain
220 T. Havermans et al. / Journal of Cystic Fibrosis 8 (2009) 218–223lot of difficulty to 4 = no difficulty) or true/false responses (1 =
very true to 4 = very false). Scores were standardized on a 0- to
100-point scale, with higher scores representing better quality of
life.
2.2.3. Work/study status
Work/study status was recorded from the Cystic Fibrosis
Quality of Life scale, teen/adult-version (CFQ-14+) and
categorized into ‘yes = working or attending study full- or
part-time’ or ‘no = not working or attending study full- or part-
time.’ Employment and school status were combined and
referred to as ‘work.’
2.3. Statistical analyses
Statistical methods used were as follows:
Pearson correlations were conducted to assess the associa-
tion between lung function, BMI and HRQoL scores. Fisher's
Exact Test was used to test the associations between medical
parameters and work/study status. Analyses of variance were
used to assess differences between groups as defined by medical
status (e.g. Pancreatic status) on domain scores of HRQoL.
Where needed, Bonferroni corrections were used to adjust for
multiple comparisons. Multivariate analyses of variance
including covariates were used to assess the relationship
between work/study status and domains of HRQoL. Clinical
parameters were used as covariates.
3. Results
3.1. HRQoL and medical status
Hypothesis 1 stated that less severe disease would be
associated with higher scores on the CFQ-R. Correlations
showed that lung function was only related to Physical
Functioning and Health Perceptions. Lower FEV1 % predicted
scores were associated with lower scores on Physical Function-
ing and a worse perception of General Health (r=0.27 and 0.38
respectively, pb0.05). With regard to BMI, the hypothesis was
confirmed for the domains Eating Disturbances and Weight.
Higher BMI was associated with higher scores on Eating
Disturbances (indicating fewer problems with eating) (r=0.44,pb0.01) and better perceptions of Weight (r=0.43, pb0.01)
and Body Image (r=0.28, pb0.05).
Analysis of variance were conducted to assess differences in
mean CFQ-R Teen/Adult domain scores depending on PA
status, pancreatic status, PAC, CFRDM status and nutritional
status, after controlling for FEV1 % predicted and BMI.
Bonferroni corrections were used to adjust for multiple
comparisons. The hypothesis that health status is related to
higher HRQoL scores was confirmed for the Weight scale in
relation to CFRDM. Patients with CFRDM reported lower
(indicating more problems) scores on the Weight scale than
patients without CFRDM (mean scores 43.65 vs. 69.88,
F=8.62, p=0.005). Body Image and Weight were also related
to nutrition status. Patients not taking high caloric supplements
scored higher on the Body Image scale compared to patients
who did take high caloric supplements (76.60 vs. 47.72,
F=10.34, p=0.002). Similarly, patients taking high caloric
supplements scored lower on the Weight scale compared to
patients not taking supplements (43.48 vs. 70.04, F=8.28,
p=0.006).
Having a PAC was associated with scores on the domains of
Physical Functioning, Treatment Burden, Role and Weight.
Patients with a PAC scored lower than patients without a PAC
on Physical Functioning (59.84 vs. 78.03, F=5.65, p=.02),
indicating that patients feel less able to participate physical
activities. They also reported a higher Treatment Burden (42.24
vs. 57.21, p=0.15), perceived more difficulties in their Role
Functioning (60.35 vs. 74.96, p=0.04) and had lower scores on
the Weight scale (41.79 vs. 71.74, p=0.001).
3.2. Work and medical status
Hypothesis 2 stated that patients who work would have less
severe disease than patients who were not working.
The results showed that patients who were working had a
significantly higher FEV1 % predicted (mean 70 vs. 57, t=
−2.61, p=0.03) than non-working patients. Tests of associa-
tions between the nominal medical variables showed that all
non-working patients (n=23) had PA in their sputum (they were
in the PA positive non-multiresistant or PA positive multi-
resistant group). This is significantly different from the group of
working patients where 13 were situated in the PA negative
Table 3
Analysis of variance of mean CFQ14+ domain scores by work/study, including
covariates (with Bonferroni adjustment for multiple comparisons).
CFQ-14+
domain
Non-working
patients mean
(SD)
Working
patients mean
(SD)
F Covariates in
the model
Physical
functioning
59.87 (5.29) 86.32 (4.14) 12.41,
p=.001
FEV1
BMI
PAC
Role 57.38 (4.79) 82.03 (3.75) 13.16,
p=.001
FEV1
BMI
PAC
Caloric
supplements
Vitality 53.82 (5.15) 66.71 (4.03) 3.11,
p=.08
FEV1
BMI
Emotional
functioning
63.07 (5.25) 73.72 (4.11) 2.04,
p=.16
FEV1
BMI
Caloric
supplements
Social 58.56 (4.32) 73.47 (3.38) 5.92,
p=.02
FEV1
BMI
Body image 69.38 (5.68) 84.21 (4.45) 3.38,
p=.07
FEV1
BMI
Caloric
supplements
Eating
disturbances
79.83 (5.38) 90.76 (4.21) 2.05, p=.16 FEV1
BMI
Caloric
supplements
Treatment
burden
51.12 (4.53) 59.68 (3.54) 1.77,
p=.19
FEV1
BMI
PAC
Health
perceptions
44.66 (6.59) 56.01 (5.15) 1.47,
p=.23
FEV1
BMI
PAC
Caloric
supplements
Weight 75.91 (5.90) 78.12 (4.62) 0.15,
p=.70
FEV1
BMI
PAC
Diabetes
Caloric
supplements
Respiratory
symptoms
66.14 (4.75) 76.19 (3.72) 2.22,
p=.14
FEV1
BMI
Digestive
symptoms
77.13 (5.01) 82.94 (3.92) 0.67,
p=.41
FEV1
BMI
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positive multiresistant status (Fisher's exact=0.44, p=.003).
Thus, although working patients were present in all three PA
groups, patients who were not working all had PA.
Non-working patients also had a PAC more often (Fisher's
exact=−0.59, p= .001) and took more caloric supplements
(Fisher's exact =−0.32, p= .01) than patients who were
working.
3.3. Work and HRQoL
Hypothesis 3 stated that, after controlling for FEV1 %
predicted, BMI and other medical parameters, patients in a work
situation rate their HRQoL higher than those not in a working
situation.
Multivariate models were constructed to assess the relation-
ship between work and domains of the CFQ-R, with medical
parameters as covariates. Table 3 shows results of the analysis
of variance of mean scores of the CFQ-R Teen/Adult domains
by work. For each domain, a model was constructed to assess
main effects of factors and covariates. In each model FEV1 %
predicted and BMI were included, in conjunction with specific
parameters specified before.
After controlling for medical variables, working patients
reported higher, but not significantly higher, than non-working
patients on the domains Vitality, Emotional Functioning, Body
Image, Eating Disturbances, Treatment Burden, Health Percep-
tion, Weight, Respiratory Symptoms and Digestive Symptoms.
For three domains the difference between working and non-
working patients was statistically significant. Working patients
reported their Physical Functioning (walking, running etc) as
better than non-working patients and this effect remained after
controlling for FEV1 % predicted, BMI and having a PAC.
Patients who worked had a better Role Perception, after taking
into account FEV1 % predicted, BMI, PAC or taking high
caloric supplements. Finally, patients who worked reported a
better Social Functioning than patient who did not work, after
controlling for FEV1 % predicted or BMI.
4. Discussion
One of the main aims of adulthood is to achieve
independence. This typically involves attending school, work-
ing and increasing financial independence. Not being able to
work has a major impact on a person's life, regardless of
whether one has a chronic illness, such as CF. This study has
investigated the association between HRQoL, medical status
and work status.
4.1. HRQoL and medical status
The first hypothesis that was tested stated that better HRQoL
would be related to less severe disease. For several domains of
the CFQ-R Teen/Adult this was confirmed. The results are
similar to those reported by others [5,18–20], with higher FEV1
% predicted relating to scores on Physical Functioning and
Health Perceptions. Higher BMI scores were related to higherscores on the Eating Disturbances, Body Image and Weight
scales. Diabetes (CFRDM) status was related to more problems
on the Weight scale, which makes sense since the occurrence of
CFRDM in a patient with CF makes it difficult to maintain
weight and to balance food to maintain normal glucose levels.
No relationship was found between CFRDM status and
Treatment Burden, which was unexpected since most patients
describe diabetes and its treatment as ‘a significant extra
burden.’ The diabetes literature reports significant correlations
between psychological variables and HRQoL when comparing
diabetes patients with non-diabetics [21]. The present findings
may be explained by the fact that diabetes is conceived as an
illness on its own, with a very specific treatment plan and
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tionnaire like the CFQ-R Teen/Adult, they may be referring to
their CF and not their diabetes. In addition, the CFQ-R does not
have questions specific to CFRDM related problems. Over the
past 10 years CFRDM has become more common in CF and
CF-specific HRQoL questionnaires should include questions
about this theme. Apart from Gee et al. [4] no studies have
reported on CFRDM in relation to HRQoL, however several
investigators have reported that CFRDM is related to decreased
life expectancy and mortality, most notably in female patients,
as well as decreased pulmonary function and body weight
reduction [22,23]. The number of diabetes patients in this
sample was small and further study of the relationship between
CFRDM and HRQoL is warranted.
Taking high caloric supplements was related to patients
reporting more problems with Weight and Body Image. When a
patient is advised to take high caloric supplements this is not
only a sign of worsening health, but also an indication that the
patient is not able to control weight by eating as s/he was used
to, which may explain the found associations. Having a PAC
was associated with lower perceptions of Physical Functioning,
higher Treatment Burden and lower perceptions of Role and
Weight. Similar results have been described by Gee et al. [4].
Most patients with a PAC need regular intravenous antibiotics
and having a PAC requires special attention with 6–8 weekly
visits to a specialist CF nurse. These issues may explain higher
scores on Treatment Burden for patients with a PAC. The
association between the impact a PAC has on patients' Physical
Functioning, Treatment Burden and Role Functioning may also
explain why having a PAC placed is a difficult decision for
some patients. It is not only a confirmation of deteriorating
health, but also of the need for more treatment.
Pseudomonas aeruginosa (PA) status was not related to any
of the CFQ-R Teen/Adult domains in the analysis. Goldbeck
et al. [24] found in a longitudinal study, that new colonization
with PA was a significant factor in explaining quality of life.
New PA colonization often changes the treatment schedule and
one could expect this to be reflected in patients' experience of
treatment burden. Patients in the present sample were colonized
with PA for a considerable period of time and the extra
treatments related to PA may not be experienced currently as an
extra burden, because ‘they are used to it.’ This consideration
also applies to pancreatic status for which no differences were
found in HRQoL. This topic needs more study, and longitudinal
studies which address the impact of PA or PI over time. For
example, perception of ‘treatment burden’ may change
depending on the treatment schedule, which is likely to increase
over time with deterioration of disease. However, treatment
burden may also change because patients ‘get used to it.’
4.2. Work and medical variables
The hypothesis that patients who are working (or studying)
have less severe disease was confirmed. Non-working patients
more often had a PAC and/or PA and also took more high
caloric supplements in comparison to working patients.
Contrary to findings of Burker et al. [16], who found nodifferences in lung function between working and non-working
patients, the non-working patients in the present sample had a
significantly lower lung function. These results were anticipated
because patients with CF who are colonized with PA need
regular treatment, daily aerosols with anti-pseudomonas anti-
biotics and regular intravenous treatment. With this increased
need for treatment, patients are advised to have a PAC to ease
the administration of intravenous antibiotics. In addition, the
recurrence of infections is often related to loss of weight for
which they have to take high caloric supplements.
4.3. HRQoL and work status
The third hypothesis proposed that working patients would
report a higher QoL than non-working patients. After control-
ling for the effects of medical variables, three domains were
significantly related to work status. Patients who work reported
a better physical functioning, role perception and social
functioning in comparison to their non-working peers. In
other words, working patients felt better physically and scored
higher on questions relating to their ability ‘to walk distances
like other people their age, walking up the stairs, carrying heavy
things, etc.’ Importantly, they reported higher on these HRQoL
items despite their lung function. This is noteworthy as patient-
reported Physical Functioning (using the CFQoL) has been
shown to be an independent predictor of survival after taking
into account key clinical variables [25]. In addition, working
patients had a more positive view of their role functioning and
reported a better social functioning, again controlling for their
medical status. Like the results of Hogg et al. [17] the present
results showed that working is importantly related to specific
domains of quality of life. Working seems to improve patients'
psychosocial well-being in spite of their medical status. This
finding is worth taking into account when advice is given about
reducing work or school load as working may protect patients
from psychological problems.
Unexpected was the finding that work status was not related
to Treatment Burden. It is possible that both groups perceived
treatment burden differently. Non-working patients had worse
disease status than working patients and needed to do more
treatment. Treatment burden for working patients may be
related to having ‘less time available for treatment.’ The
Treatment Burden scale of the CFQ-R Teen/Adult may not be
specific enough to identify underlying differences and this
needs further investigation.
4.4. Limitations
A limitation of this study is the relatively small, cross-
sectional sample. Also, for patients with CF work status
depends on many factors, both medical and psychosocial.
Financial issues have not been examined, but may play a vital
role. Thirdly, some of the expected associations between
domains of HRQoL measured by the CFQ-R Teen/Adult were
not found. For example, no differences were found on treatment
burden in relation to CFRDM status or work status, which we
expected based on comments made by patients. It is possible
223T. Havermans et al. / Journal of Cystic Fibrosis 8 (2009) 218–223that the CFQ-R Teen/Adult needs updating to make sure it taps
potential new issues that are related to HRQoL in adult patients
with CF.
4.5. Conclusion
The results point to an important clinical concern, namely
that advising patients to stop working is a key issue for both the
patient and the CF team. Differences in perception of the
HRQoL domains physical functioning, role and social function-
ing between working and non-working patients may explain
why in clinic we observe that the advice to reduce working
hours or to stop working is often met with strong opposition and
emotions. Patients and CF teams need to have open discussions
about this dilemma. Prospective studies need to look at whether
the demands of a working life speed up the process of
deterioration and how patients weigh out their decision between
quality of life and medical condition.
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